中华急诊医学杂志
中華急診醫學雜誌
중화급진의학잡지
CHINESE JOURNAL OF EMERGENCY MEDICINE
2012年
2期
193-197
,共5页
朱仁洋%楼敏%徐敏%严余清%吴继敏%周炯%包颖颖%胡海涛%宋水江%丁关萍
硃仁洋%樓敏%徐敏%嚴餘清%吳繼敏%週炯%包穎穎%鬍海濤%宋水江%丁關萍
주인양%루민%서민%엄여청%오계민%주형%포영영%호해도%송수강%정관평
静脉溶栓%脑梗死%重组组织型纤溶酶原激活剂%出血转化%穿支动脉%神经功能%中国缺血性中风亚型
靜脈溶栓%腦梗死%重組組織型纖溶酶原激活劑%齣血轉化%穿支動脈%神經功能%中國缺血性中風亞型
정맥용전%뇌경사%중조조직형섬용매원격활제%출혈전화%천지동맥%신경공능%중국결혈성중풍아형
Intravenous thrombolysis%Cerebral infarct%Recombinant tissue plasminogen activator (rtPA)%Hemorrhagic transformation(HT)%Penetrating artery%Neurological function%Chinese ischemic stroke subclassification
目的 对比穿支动脉区孤立性梗死与其他类型脑梗死经静脉rtPA溶栓治疗后出血转化及神经功能结局的差异,明确穿支动脉区孤立性梗死静脉溶栓的安全性和有效性.方法 回顾分析了浙江大学医学院附属第二医院神经内科前瞻性收集的2009.06-2011.04期间接受静脉rtPA溶栓治疗的缺血性中风患者资料,包括性别、年龄、既往史、溶栓时间、基线NIHSS、血压、血糖、电解质、凝血谱、心电图、头颅MRI、颅内外MRA(或CTA)等,按照中国缺血性中风亚型(CISS)标准1予以病因分组.结果 共75例患者接受静脉rtPA治疗,年龄(67.4±12.7)岁,女性25例,占33.3%;溶栓前NIHSS(12.3±6.4)分;发病至溶栓时间:(239.6±97.5)min; 72例(96%)在24 h接受多模式MRI复查.共24例(32%)示溶栓后出血转化,4例(5.3%)为症状性出血.22例(29.3%)患者为穿支动脉区域孤立性梗死,仅1例(1.3%)发生出血转化.Logistic回归分析发现,穿支动脉区孤立性梗死明显降低溶栓后的出血转化风险(OR=0.075,95%CI:0.008~0.663; P=0.020).并发现,82%的穿支动脉区孤立性梗死患者的1月mRS评分≤2,其神经功能结局较其梗死好(P<0.01).结论 穿支动脉区域孤立梗死患者相对于其他类型脑梗死患者在经静脉rtPA溶栓治疗后,显示出更低的出血转化率和较好的神经功能结局,故对 此类患者的静脉溶栓治疗可更积极.
目的 對比穿支動脈區孤立性梗死與其他類型腦梗死經靜脈rtPA溶栓治療後齣血轉化及神經功能結跼的差異,明確穿支動脈區孤立性梗死靜脈溶栓的安全性和有效性.方法 迴顧分析瞭浙江大學醫學院附屬第二醫院神經內科前瞻性收集的2009.06-2011.04期間接受靜脈rtPA溶栓治療的缺血性中風患者資料,包括性彆、年齡、既往史、溶栓時間、基線NIHSS、血壓、血糖、電解質、凝血譜、心電圖、頭顱MRI、顱內外MRA(或CTA)等,按照中國缺血性中風亞型(CISS)標準1予以病因分組.結果 共75例患者接受靜脈rtPA治療,年齡(67.4±12.7)歲,女性25例,佔33.3%;溶栓前NIHSS(12.3±6.4)分;髮病至溶栓時間:(239.6±97.5)min; 72例(96%)在24 h接受多模式MRI複查.共24例(32%)示溶栓後齣血轉化,4例(5.3%)為癥狀性齣血.22例(29.3%)患者為穿支動脈區域孤立性梗死,僅1例(1.3%)髮生齣血轉化.Logistic迴歸分析髮現,穿支動脈區孤立性梗死明顯降低溶栓後的齣血轉化風險(OR=0.075,95%CI:0.008~0.663; P=0.020).併髮現,82%的穿支動脈區孤立性梗死患者的1月mRS評分≤2,其神經功能結跼較其梗死好(P<0.01).結論 穿支動脈區域孤立梗死患者相對于其他類型腦梗死患者在經靜脈rtPA溶栓治療後,顯示齣更低的齣血轉化率和較好的神經功能結跼,故對 此類患者的靜脈溶栓治療可更積極.
목적 대비천지동맥구고립성경사여기타류형뇌경사경정맥rtPA용전치료후출혈전화급신경공능결국적차이,명학천지동맥구고립성경사정맥용전적안전성화유효성.방법 회고분석료절강대학의학원부속제이의원신경내과전첨성수집적2009.06-2011.04기간접수정맥rtPA용전치료적결혈성중풍환자자료,포괄성별、년령、기왕사、용전시간、기선NIHSS、혈압、혈당、전해질、응혈보、심전도、두로MRI、로내외MRA(혹CTA)등,안조중국결혈성중풍아형(CISS)표준1여이병인분조.결과 공75례환자접수정맥rtPA치료,년령(67.4±12.7)세,녀성25례,점33.3%;용전전NIHSS(12.3±6.4)분;발병지용전시간:(239.6±97.5)min; 72례(96%)재24 h접수다모식MRI복사.공24례(32%)시용전후출혈전화,4례(5.3%)위증상성출혈.22례(29.3%)환자위천지동맥구역고립성경사,부1례(1.3%)발생출혈전화.Logistic회귀분석발현,천지동맥구고립성경사명현강저용전후적출혈전화풍험(OR=0.075,95%CI:0.008~0.663; P=0.020).병발현,82%적천지동맥구고립성경사환자적1월mRS평분≤2,기신경공능결국교기경사호(P<0.01).결론 천지동맥구역고립경사환자상대우기타류형뇌경사환자재경정맥rtPA용전치료후,현시출경저적출혈전화솔화교호적신경공능결국,고대 차류환자적정맥용전치료가경적겁.
Objective To investigate the safety and efficacy of intravenous thrombolytic therapy with recombinant tissue plasminogen activator(rtPA)in patients with isolated penetrating artery territory infarct (IPAI).Methods Data of retrospectively collected clinical,laboratory,and radiological from 75 consecutive patients with acute ischemic stroke treated with intravenous rtPA therapy from June 2009 to April 2011.Etiological classification was carried out according to the Chinese Ischemic Stroke Classification of Subgroups(CISS).The rates of hemorrhagic transformation(HT)and clinical outcomes of patients were compared between IPAI group and non-IPAI group.Results All 75 patients with mean age of 67.4years and 25(33.3%)fenale,were treated with intravenous rtPA.Before treatment,their average score of the National Institutes of Health Stroke Scale(NIHSS)was 12.3 ± 6.4,and mean length of time from onset to treatment was 239.6 ±97.5 minutes.After thrombolytic therapy,the radiological HT was found in 24 patients(32%).Symptomatic intracraneal hemorrhage(ICH)occurred in 4 patients(5.3%).Of 22 (29.3%)patients with IPAI,only one experienced HT.Logistic regression analysis suggested that IPAI wasan individualized predictor used alone for determining the low risk of HT.In the patients with IPAI,82% of them had an individual clinical outcome(mRS < 2)one month after onset,and the neurological outcomes were better in patients with IPAI than those in patients with non-IPAI(P < 0.01).Conclusions The risk of hemorrhagic complication was low and the clinical outcome was good in patients with isolated penetrating artery territory infarct after intravenous thrombolytic therapy with rtPA.Imaging diagnosis of IPAI might facilitate the treatment with rtPA in this cohort of patients.